---
title: "This Moody's Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293031098.md"
description: "Wall Street analysts initiated coverage on five stocks with bullish outlooks: BMO rated Crown Holdings (CCK) Outperform ($130 target), BTIG rated Omada Health (OMDA) Buy ($30), Canaccord Genuity rated Jazz Pharmaceuticals (JAZZ) Buy ($290), Stephens & Co. rated Dutch Bros (BROS) Overweight ($80), and Jefferies rated Moody’s Corp (MCO) Buy ($610)."
datetime: "2026-07-17T11:15:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293031098.md)
  - [en](https://longbridge.com/en/news/293031098.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293031098.md)
---

# This Moody's Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

-   BMO Capital analyst Ketan Mamtora initiated coverage on **Crown Holdings Inc** (NYSE:CCK) with an Outperform rating and announced a price target of $130. Crown Holdings shares closed at $117.02 on Thursday. See how other analysts view this stock.
-   BTIG analyst David Larsen initiated coverage on **Omada Health Inc** (NASDAQ:OMDA) with a Buy rating and announced a price target of $30. Omada Health shares closed at $23.67 on Thursday. See how other analysts view this stock.
-   Canaccord Genuity analyst Gary Nachman initiated coverage on **Jazz Pharmaceuticals PLC** (NASDAQ:JAZZ) with a Buy rating and announced a price target of $290. Jazz Pharmaceuticals shares closed at $242.18 on Thursday. See how other analysts view this stock.
-   Stephens & Co. analyst Jim Salera initiated coverage on **Dutch Bros Inc** (NYSE:BROS) with an Overweight rating and announced a price target of $80. Dutch Bros shares closed at $65.35 on Thursday. See how other analysts view this stock.
-   Jefferies analyst Surinder Thind initiated coverage on **Moody’s Corp** (NYSE:MCO) with a Buy rating and announced a price target of $610. Moodys shares closed at $519.02 on Thursday. See how other analysts view this stock.

Considering buying MCO stock? Here’s what analysts think:

_Photo via Shutterstock_

### Related Stocks

- [BROS.US](https://longbridge.com/en/quote/BROS.US.md)
- [JAZZ.US](https://longbridge.com/en/quote/JAZZ.US.md)
- [CCK.US](https://longbridge.com/en/quote/CCK.US.md)
- [OMDA.US](https://longbridge.com/en/quote/OMDA.US.md)
- [MCO.US](https://longbridge.com/en/quote/MCO.US.md)

## Related News & Research

- [Here's What Analysts Are Forecasting For Dutch Bros Inc. (NYSE:BROS) After Its Second-Quarter Results](https://longbridge.com/en/news/295400019.md)
- [Moody's Corporation $MCO Stock Holdings Lifted by Assenagon Asset Management S.A.](https://longbridge.com/en/news/295293940.md)
- [Analysts Are Slashing Price Targets on AppLovin Stock. Here's Why.](https://longbridge.com/en/news/295259264.md)
- [Arrowstreet Capital Limited Partnership Buys Shares of 91,022 Omada Health, Inc. $OMDA](https://longbridge.com/en/news/295192351.md)
- [These Analysts Increase Their Forecasts On Jazz Pharmaceuticals Following Q2 Results](https://longbridge.com/en/news/294821044.md)